Loading data for CANF — first visit, this takes a few seconds.
Can-Fite BioPharma Ltd. (CANF)
NYSE American: CANF
· リアルタイム株価 · USD
3.45
-0.13 (-3.63%)
終値時点: Aug 18, 2026, 3:52 PM
3.45
+2.55%
寄り付き前: 6:43 AM
Can-Fite BioPharma Ltd. (CANF) Stock Price, Analysis & Data
-3.63% (1D)
CANFについて
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cance...
セクター Healthcare
IPO日 Nov 6, 2012
従業員数 5
上場取引所 NYSE American
ティッカー CANF
ウェブサイト https://www.canfite.com
決算サプライズ
Can-Fite BioPharmaはMar 28, 2024に四半期決算を発表しました:
2ページ中1ページ
